Inhibikase Therapeutics
IKT
IKT
21 hedge funds and large institutions have $7.78M invested in Inhibikase Therapeutics in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
21
Holders Change
+7
Holders Change %
+50%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
6
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
ACM
1
ACT Capital Management
Wayne,
Pennsylvania
|
$1.92M |
2 |
2
Millennium Management
New York
|
$192K |
3 |
AC
3
Antara Capital
New York
|
$576K |
4 |
4
Bank of New York Mellon
New York
|
$75K |
5 |
5
BlackRock
New York
|
$96K |
Top Sellers
1 |
ACM
1
Altium Capital Management
New York
|
$0 |
2 |
WAM
2
Warberg Asset Management
Winnetka,
Illinois
|
$49K |
3 |
HF
3
HRT Financial
New York
|
$0 |